phrykt

Idexx Laboratories (IDXX) share buybacks: $1.2B

Idexx Laboratories spent $1.2B buying back its own shares in the year ended Dec 31, 2025, up 45.4% from $837M a year earlier.

From Idexx Laboratories's filings with the SEC · Read the filing · IDXX stock page

Idexx Laboratories share buybacks by year

$747M2021$820M2022$71.9M2023$837M2024$1.2B2025

#172 of 1,890 US companies by share buybacks · See the full ranking

Year endedShare buybacksChange
Dec 31, 2025$1.2B+45%
Dec 31, 2024$837M+1064%
Dec 31, 2023$71.9M-91%
Dec 31, 2022$820M+10%
Dec 31, 2021$747M–

Share buybacks of similar companies

Companies in the same industry as Idexx Laboratories, by SEC industry code, with the closest share buybacks. Each name opens the same page for that company.

CompanyShare buybacks, latest yearYear ended
Gilead Sciences$1.9BDec 31, 2025
Royalty Pharma$1.2BDec 31, 2025
Idexx Laboratories$1.2BDec 31, 2025
United Therapeutics$1BDec 31, 2025
AbbVie$980MDec 31, 2025
Exelixis$948MJan 2, 2026
Abbott Laboratories$893MDec 31, 2025

Questions and answers

What is Idexx Laboratories's share buybacks?

Idexx Laboratories spent $1.2B buying back its own shares in the year ended Dec 31, 2025, up 45.4% from $837M a year earlier.

Numbers as reported in Idexx Laboratories's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology